<?xml version="1.0" encoding="UTF-8"?>
<p id="p0135">The study at CBER, FDA was conducted with de-identified samples under Research Involving Human Subjects (RIHSC) exemption #15-0B, and all assays performed fell within the permissible usages in the original consent.</p>
